Hanil Chemical IND한일화학
007770 · KOSDAQ · ₩007770 · 한일화학
₩7,780▼ ₩10 (0.13%)End-of-day · Oct 30, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | ₩124B | ₩125B | ₩122B | ₩156B | ₩114B |
| Cost of sales | ₩125B | ₩118B | ₩119B | ₩139B | ₩105B |
| Gross profit | −₩536M | ₩6.9B | ₩3.2B | ₩18B | ₩9B |
| Operating income | −₩12B | −₩6.6B | −₩9.4B | ₩4.9B | ₩502M |
| Net income | −₩20B | ₩4.1B | −₩15B | ₩4B | ₩23B |
| Net income to shareholders | −₩18B | ₩5B | −₩15B | ₩4.3B | ₩22B |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Total assets | ₩128B | ₩144B | ₩147B | ₩157B | ₩161B |
| Current assets | ₩48B | ₩56B | ₩56B | ₩65B | ₩78B |
| Cash and equivalents | ₩6.4B | ₩5.7B | ₩4.6B | ₩13B | ₩23B |
| Total liabilities | ₩41B | ₩36B | ₩43B | ₩38B | ₩48B |
| Current liabilities | ₩29B | ₩32B | ₩38B | ₩34B | ₩45B |
| Borrowings | ₩23B | ₩23B | ₩19B | ₩22B | ₩18B |
| Total equity | ₩87B | ₩108B | ₩104B | ₩119B | ₩113B |
| Shareholders' equity | ₩89B | ₩108B | ₩104B | ₩118B | ₩113B |
Cash flow
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash from operations | ₩2.8B | −₩7.4B | −₩2.2B | −₩6.4B | −₩7.1B |
| Capital spending | ₩1.1B | ₩764M | ₩6.8B | ₩7.1B | ₩15B |
| Free cash flow | ₩1.7B | −₩8.2B | −₩9B | −₩13B | −₩22B |
| Dividends paid | ₩176M | ₩176M | ₩351M | ₩421M | ₩176M |
Consolidated where available. Amounts in won.
Also known as: Hanil Chemical IND / 한일화학 / 007770 / KRX:007770
Source: KRX statistical information